Arcadia Biosciences, Inc. (NASDAQ:RKDA) Files An 8-K Submission of Matters to a Vote of Security Holders

Item 5.07.

At the annual meeting of stockholders of the Company held on June
7, 2017 (the Annual Meeting), stockholders holding and entitled
to vote 39,280,292 shares of common stock of the Company, or
approximately 92.06% of the total outstanding shares of common
stock on the record date for the Annual Meeting, were present in
person or by proxy. At the Annual Meeting, the stockholders voted
on the following three proposals, each of which is described in
detail in the definitive proxy statement filed with the
Securities and Exchange Commission on April 26, 2017.

The final results for each of the matters considered at the
Annual Meeting were as follows:

PROPOSAL I: Election of Directors

Each of the director nominees was elected to serve as a Class II
director until the Companys annual meeting of stockholders in
2020, or until his successor is duly elected and qualified, or
his earlier resignation, death, or removal. Due to plurality
election, votes could only be cast in favor of or withheld from
the nominees and thus votes against were not applicable. The
results of the election were as follows:

PROPOSAL II: Reduction of Authorized Common Stock Shares

The proposed amendment to the Companys Certificate of
Incorporation to decrease the number of authorized shares of
common stock from 400,000,000 shares to 150,000,000 shares, was
ratified by the affirmative votes of the stockholders. There were
no broker non-votes on this proposal. The results of the
ratification were as follows:

PROPOSAL III: Ratification of Selection of Independent Registered
Public Accountants

The appointment of Deloitte Touche LLP as the Companys
independent registered public accountants for the year ending
December 31, 2017, was ratified by the affirmative votes of the
stockholders. There were no broker non-votes on this proposal.
The results of the ratification were as follows:

About Arcadia Biosciences, Inc. (NASDAQ:RKDA)

Arcadia Biosciences, Inc. is an agricultural biotechnology trait company. The Company develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. It has a pipeline of products in development incorporating its traits, including products that are in advanced stages of development or on the market. Its crop yield traits are utilized by its partners to develop higher yielding seeds for global crops, including wheat, rice, soybean, corn, and sugarcane, as well as for other crops, such as cotton, turf and trees. The Company’s portfolio of agricultural productivity traits includes Nitrogen Use Efficiency (NUE), Water Use Efficiency (WUE), Drought Tolerance (DT), Salinity Tolerance (ST) and Herbicide Tolerance. It has presence in the United States, Africa, India, the United Arab Emirates, Belgium, France and Canada.